Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.

ABSTRACT:

SUBMITTER: Cole CB 

PROVIDER: S-EPMC10131449 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature